Cargando…

Cell-based technologies for Huntington’s disease

Huntington's disease (HD) is a fatal genetic disorder, which causes the progressive breakdown of neurons in the human brain. HD deteriorates human physical and mental abilities over time and has no cure. Stem cell-based technologies are promising novel treatments, and in HD, they aim to replace...

Descripción completa

Detalles Bibliográficos
Autores principales:	Haddad, Mônica Santoro, Wenceslau, Cristiane Valverde, Pompeia, Celine, Kerkis, Irina
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Associação de Neurologia Cognitiva e do Comportamento 2016
Materias:	Views & Reviews
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5619267/ https://www.ncbi.nlm.nih.gov/pubmed/29213471 http://dx.doi.org/10.1590/s1980-5764-2016dn1004006

Ejemplares similares

Neural and mesenchymal stem cells in animal models of Huntington’s disease: past experiences and future challenges
por: Kerkis, Irina, et al.
Publicado: (2015)

Restoration of BDNF, DARPP32, and D2R Expression Following Intravenous Infusion of Human Immature Dental Pulp Stem Cells in Huntington’s Disease 3-NP Rat Model
por: Wenceslau, Cristiane Valverde, et al.
Publicado: (2022)

Mesenchymal Stem Cell Benefits Observed in Bone Marrow Failure and Acquired Aplastic Anemia
por: Gonzaga, Vivian Fonseca, et al.
Publicado: (2017)

Revisiting the neuropsychiatry of Huntington's disease
por: Teixeira, Antonio Lucio, et al.
Publicado: (2016)

Clinical recommendations to guide physical therapy practice for Huntington disease
por: Quinn, Lori, et al.
Publicado: (2020)

Human Immature Dental Pulp Stem Cells Did Not Graft into a Preexisting Human Lung Adenocarcinoma
por: da Silva, Joyce Macedo, et al.
Publicado: (2022)

Therapeutic Potential of Human Immature Dental Pulp Stem Cells Observed in Mouse Model for Acquired Aplastic Anemia
por: Gonzaga, Vivian Fonseca, et al.
Publicado: (2022)

Exosomes in the Tumor Microenvironment: From Biology to Clinical Applications
por: da Costa, Vitor Rodrigues, et al.
Publicado: (2021)

Advanced cell therapy with low tissue factor loaded product NestaCell® does not confer thrombogenic risk for critically ill COVID-19 heparin-treated patients
por: Araldi, Rodrigo Pinheiro, et al.
Publicado: (2022)

Semantic, phonologic, and verb fluency in Huntington’s disease
por: Azambuja, Mariana Jardim, et al.
Publicado: (2007)

Advances and Challenges on Cancer Cells Reprogramming Using Induced Pluripotent Stem Cells Technologies
por: Câmara, Diana Aparecida Dias, et al.
Publicado: (2016)

Diagnostic disclosure in Alzheimer’s Disease: A review
por: Raicher, Irina, et al.
Publicado: (2008)

Modern Genome Editing Technologies in Huntington’s Disease Research
por: Malankhanova, Tuyana B., et al.
Publicado: (2017)

Telemedicine technology and implications for reproductive office operations
por: Uustal, Matt, et al.
Publicado: (2020)

Parkinson's Disease and Wearable Technology: An Indian Perspective
por: Bagrodia, Vaishali, et al.
Publicado: (2022)

Telemedicine in reproductive medicine—implications for technology and clinical practice
por: Sigman, Mark
Publicado: (2020)

Alzheimer's disease care and management: Role of information technology
por: Thota, Hanuman, et al.
Publicado: (2007)

Neuropathology of frontotemporal lobar degeneration: a review
por: Bahia, Valéria Santoro, et al.
Publicado: (2013)

Addressing the Global Challenges of COVID-19 and Other Pulmonary Diseases with Microfluidic Technology
por: Xie, Yuliang, et al.
Publicado: (2022)

Technology and healthcare costs
por: Kumar, R Krishna
Publicado: (2011)

Voices of the new generation: being a junior PI in a developing country
por: Fernandez-Valverde, Selene L.
Publicado: (2020)

Cognitive, functional and behavioral assessment: Alzheimer’s disease
por: Chaves, Márcia L.F., et al.
Publicado: (2011)

Imaging Alzheimer's disease pathophysiology with PET
por: Schilling, Lucas Porcello, et al.
Publicado: (2016)

Know thy enemy: Why are tumor-infiltrating regulatory T cells so deleterious?
por: Facciabene, Andrea, et al.
Publicado: (2012)

Irritability in Huntington’s Disease
por: Karagas, Nicholas E., et al.
Publicado: (2020)

Neurologic complications of sickle cell disease in Africa: A systematic review and meta-analysis
por: Noubiap, Jean Jacques, et al.
Publicado: (2017)

The digital heart–lung unit: applications of exponential technology
por: Sadeghi, Amir H, et al.
Publicado: (2021)

Lung Transplantation for COVID-19–related Lung Disease: Clinical Experience and Call for a Global Registry
por: Weder, Max M., et al.
Publicado: (2022)

Next generation sequencing technologies and the changing landscape of phage genomics
por: Klumpp, Jochen, et al.
Publicado: (2012)

Huntington Disease in Asia
por: Xu, Miao, et al.
Publicado: (2015)

Views on Structure-based design of antiviral drug candidates targeting the SARS-CoV-2 main protease by Dai et al. (2020)
por: Odhar, Hasanain Abdulhameed
Publicado: (2020)

The updated development of blood-based biomarkers for Huntington’s disease
por: Zhang, Sirui, et al.
Publicado: (2023)

DEC-205 is a cell surface receptor for CpG oligonucleotides
por: Caminschi, Irina, et al.
Publicado: (2013)

Cortical and Striatal Circuits in Huntington’s Disease
por: Blumenstock, Sonja, et al.
Publicado: (2020)

Therapeutic Strategies in Huntington's Disease
por: Kanazawa, Ichiro
Publicado: (2006)

Neurodegenerative processes in Huntington's disease
por: Bano, D, et al.
Publicado: (2011)

Neuropsychiatric Burden in Huntington’s Disease
por: Paoli, Ricardo Augusto, et al.
Publicado: (2017)

PET Imaging in Huntington’s Disease
por: Roussakis, Andreas-Antonios, et al.
Publicado: (2015)

The Neurodevelopmental Hypothesis of Huntington’s Disease
por: van der Plas, Ellen, et al.
Publicado: (2020)

Therapeutic Advances for Huntington’s Disease
por: Kumar, Ashok, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_j0in8i03uc6ub5ibu2embsvv6j